...
首页> 外文期刊>Cancer chemotherapy and pharmacology. >Uncoupling protein downregulation in doxorubicin-induced heart failure improves mitochondrial coupling but increases reactive oxygen species generation.
【24h】

Uncoupling protein downregulation in doxorubicin-induced heart failure improves mitochondrial coupling but increases reactive oxygen species generation.

机译:阿霉素诱导的心力衰竭中的解偶联蛋白下调改善了线粒体偶联,但增加了活性氧的产生。

获取原文
获取原文并翻译 | 示例

摘要

PURPOSE: Doxorubicin-based chemotherapy is limited by the development of dose-dependent left ventricular dysfunction and congestive heart failure caused by reactive oxygen species (ROS). Uncoupling proteins (UCP) can inhibit mitochondrial ROS production as well as decrease myocyte damage from exogenous ROS. Prior studies have shown that cardiac UCP2 and UCP3 mRNA expression is decreased with acute doxorubicin treatment. However, the expression of UCP protein in hearts with doxorubicin cardiotoxicity and the resultant changes in mitochondrial function and oxidant stress have not been determined. METHODS: Heart failure was induced in Sprague-Dawley rats with intraperitoneal injections of doxorubicin (2 mg/kg t.i.w., total dose: 18 mg/kg). Mitochondria were isolated from mice receiving doxorubicin or saline injections for determination of UCP2 and UCP3 expression. In addition, mitochondrial respiration, ATP synthesis and ROS production were determined. RESULTS: Doxorubicin-induced heart failure was associated with significant decreases in UCP2 and UCP3 protein expression compared with nonfailing hearts (P < 0.05). While the rates of state 3 and state 4 respiration and ATP synthesis were lower in mitochondria isolated from failing hearts, the respiratory control ratio was 15% higher (P < 0.05), and the ratio of ATP production to oxygen consumption was 25% higher (P < 0.05) in mitochondria from failing hearts, indicating greater coupling between citric acid cycle flux and mitochondrial ATP synthesis. However, the decrease in UCP expression was associated with 50% greater mitochondrial ROS generation (P < 0.05). CONCLUSIONS: Downregulation of myocardial UCP2 and UCP3 in the setting of doxorubicin-induced heart failure is associated with improved efficiency of ATP synthesis, which might compensate for abnormal energy metabolism. However, this beneficial effect is counterbalanced by greater oxidant stress.
机译:目的:基于阿霉素的化学疗法受到活性氧(ROS)引起的剂量依赖性左心功能不全和充血性心力衰竭的限制。解偶联蛋白(UCP)可以抑制线粒体ROS的产生,并减少外源性ROS引起的心肌细胞损伤。先前的研究表明,急性阿霉素治疗可降低心脏UCP2和UCP3 mRNA的表达。但是,尚未确定UCP蛋白在具有阿霉素心脏毒性的心脏中的表达以及由此引起的线粒体功能和氧化应激变化。方法:腹腔注射阿霉素(2 mg / kg t.i.w.,总剂量:18 mg / kg)在Sprague-Dawley大鼠中诱发心力衰竭。从接受阿霉素或盐水注射的小鼠中分离线粒体,以测定UCP2和UCP3的表达。另外,测定了线粒体呼吸,ATP合成和ROS产生。结果:与未失败的心脏相比,阿霉素引起的心力衰竭与UCP2和UCP3蛋白表达的显着降低有关(P <0.05)。从衰竭心脏分离的线粒体中,状态3和状态4的呼吸和ATP合成的速率较低,但呼吸控制率高15%(P <0.05),而ATP产生与耗氧量的比率高25%( P <0.05)来自衰竭心脏的线粒体,表明柠檬酸循环通量与线粒体ATP合成之间存在更大的耦合。但是,UCP表达的降低与线粒体ROS生成增加50%有关(P <0.05)。结论:在阿霉素诱发的心力衰竭的情况下,心肌UCP2和UCP3的下调与ATP合成效率的提高有关,这可能补偿了异常的能量代谢。然而,更大的氧化压力抵消了这种有益效果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号